picosulfate

MECHANISM OF ACTION

 picosulfate is a stimulant laxative that is activated by intestinal bacteria in the colon. Once converted to its active form, it stimulates the enteric nerves in the intestinal wall, increasing peristalsis and promoting the secretion of water and electrolytes into the bowel. This softens the stool and accelerates intestinal transit, leading to easier bowel evacuation.

PHARMACOKINETICS

Absorption

picosulfate is minimally absorbed from the gastrointestinal tract after oral administration. It remains largely inactive until it reaches the colon, where it is metabolized by intestinal bacteria into its active form. Because systemic absorption is very low, its action is mainly localized within the colon, and systemic side effects are uncommon.

Distribution

picosulfate has minimal systemic distribution because it is poorly absorbed from the gastrointestinal tract. The small amount that may be absorbed does not significantly circulate in the bloodstream or accumulate in tissues. Its primary site of action remains the colon, where it is converted by gut bacteria into its active metabolite, resulting in a localized laxative effect.

Metabolism

picosulfate is a prodrug that is not significantly metabolized in the small intestine or systemically. In the colon, it is converted by bacterial enzymes into its active metabolite, BHPM (bis-(p-hydroxyphenyl)-pyridyl-2-methane), which produces the laxative effect by stimulating colonic motility and secretion. Any minimal absorbed fraction undergoes limited hepatic conjugation.

Elimination

picosulfate and its metabolites are primarily eliminated via the feces after local action in the colon. A small amount of the active metabolite that is absorbed systemically is excreted in the urine, mainly as inactive conjugated forms. Overall, elimination is largely fecal, reflecting its minimal systemic absorption.

PHARMACODYNAMICS

picosulfate is a stimulant laxative that acts locally in the colon after conversion by intestinal bacteria into its active metabolite. The active form stimulates the enteric nervous system, leading to increased peristaltic contractions and enhanced propulsion of intestinal contents. It also promotes secretion of water and electrolytes into the intestinal lumen, which softens stool and increases stool volume. These combined effects accelerate bowel transit and result in defecation, with action primarily confined to the large intestine.

ADMINISTRATION

picosulfate is administered orally, usually in the form of tablets, drops, or powder solutions depending on the formulation. For constipation, it is typically taken once daily, often at night to produce a bowel movement the following morning. For bowel preparation before procedures like colonoscopy, it is given in specific split-dose regimens along with adequate fluid intake to ensure effective cleansing of the intestine.

DOSAGE AND STRENGTH

picosulfate is available in oral tablet and drop formulations, commonly in strengths of 5 mg tablets and 7.5 mg/mL drops. For constipation, the usual adult dose is 5–10 mg once daily, adjusted based on response. For bowel preparation, higher doses are used in combination products and are given as directed along with adequate fluids.

DRUG INTERACTIONS

picosulfate may increase the risk of electrolyte imbalance when used with diuretics or corticosteroids. It can also enhance the effects of other laxatives and reduce absorption of oral drugs due to increased intestinal transit time. Caution is needed with medications affected by potassium levels, such as cardiac glycosides.

FOOD INTERACTIONS

picosulfate has no significant direct food interactions. However, taking it with large amounts of food may delay its laxative effect slightly. Adequate fluid intake is recommended to support its action and prevent dehydration. In bowel preparation regimens, patients are usually advised to follow a clear liquid diet for better effectiveness.

CONTRAINDICATIONS

picosulfate is contraindicated in patients with intestinal obstruction, acute abdominal conditions such as appendicitis or inflammatory bowel disease flare-ups, and severe dehydration. Caution is also required in patients with severe electrolyte imbalance or unexplained abdominal pain

SIDE EFFECTS

• Abdominal cramps

• Abdominal pain

• Bloating

• Dehydration (with overuse)

• Electrolyte imbalance (especially hypokalemia)

• Dizziness

• Laxative dependence (with prolonged use)

OVER DOSAGE

• Severe diarrhea 

• Excessive abdominal cramps 

• Dehydration 

• Electrolyte imbalance (especially hypokalemia) 

• Hypotension (due to fluid loss)

TOXICITY

picosulfate has minimal systemic absorption. When it occurs, it is usually due to excessive or prolonged use and presents mainly as severe diarrhea, dehydration, and electrolyte imbalance, especially hypokalemia.